首页> 外文期刊>Life sciences >Activation of protein kinase B/Akt by alpha1-adrenoceptors in the human prostate
【24h】

Activation of protein kinase B/Akt by alpha1-adrenoceptors in the human prostate

机译:人前列腺中α1-肾上腺素受体对蛋白激酶B / Akt的激活

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: Besides their role in contraction, α1-adrenoceptors may be involved in prostate hyperplasia. This would require receptor signaling by growth-promoting pathways. Akt (syn. Protein kinase B) is an important regulator of growth and differentiation. Objective: To investigate whether α1-adrenoceptors in the human prostate activate Akt. Main methods: Prostate tissue was obtained from patients undergoing radical prostatectomy. Akt expression was investigated by RT-PCR, Western blot, and immunohistochemistry. Akt activation by noradrenaline (30 μM) and phenylephrine (10 μM) was assessed by Western blot analyses with a phospho-specific antibody. The effects of the Akt inhibitors FPA-124 and 10-DEBC on phenylephrine-, noradrenaline- and electric field stimulation- (EFS-) induced contraction were studied in myographic measurements. Key findings: mRNA of all three Akt isoforms (Akt1, Akt2, Akt3) was detected by RT-PCR in all prostate samples (n = 6 patients). Protein expression was confirmed by Western blot analysis (n = 8 patients). Immunohistochemical staining for Akt revealed strong immunoreactivity in prostate smooth muscle cells (n = 5 patients). Stimulation of prostate tissues with noradrenaline (30 μM, n = 8 patients) or phenylephrine (10 μM, n = 7 patients) caused significant Akt phosphorylation at serine-473, indicating activation of Akt. FPA124 and 10-DEBC were without effects on noradrenaline-, phenylephrine-, or EFS-induced contraction of prostate strips. Significance: Prostate α1-adrenoceptors activate Akt. Consequently, Akt is a target of α1-blocker therapy, which has been unknown to date. Our findings point to functions of prostate α1-adrenoceptors besides contraction.
机译:目的:α1-肾上腺素受体除了在收缩中发挥作用外,还可能参与前列腺增生。这将需要通过促生长途径的受体信号传导。 Akt(蛋白激酶B的合成)是生长和分化的重要调节剂。目的:研究人前列腺中的α1-肾上腺素受体是否激活Akt。主要方法:前列腺组织取自接受前列腺根治术的患者。通过RT-PCR,蛋白质印迹和免疫组化研究Akt表达。用磷酸特异性抗体通过蛋白质印迹分析评估去甲肾上腺素(30μM)和去氧肾上腺素(10μM)的Akt激活。在肌电图测量中研究了Akt抑制剂FPA-124和10-DEBC对去氧肾上腺素,去甲肾上腺素和电场刺激(EFS)引起的收缩的影响。关键发现:通过RT-PCR在所有前列腺样品(n = 6例患者)中检测到所有三种Akt亚型(Akt1,Akt2,Akt3)的mRNA。蛋白表达通过蛋白质印迹分析证实(n = 8例患者)。 Akt的免疫组织化学染色显示前列腺平滑肌细胞中有很强的免疫反应性(n = 5例)。用去甲肾上腺素(30μM,n = 8例患者)或去氧肾上腺素(10μM,n = 7例)刺激前列腺组织会导致丝氨酸473处的Akt磷酸化显着,表明Akt的激活。 FPA124和10-DEBC对去甲肾上腺素,去氧肾上腺素或EFS引起的前列腺带收缩没有影响。意义:前列腺α1-肾上腺素能激活Akt。因此,Akt是α1受体阻滞剂治疗的靶标,迄今为止尚不清楚。我们的研究结果指出了前列腺α1-肾上腺素受体除了收缩功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号